United States · Bill · S
S. 3582 (109th)
Preserve Access to Affordable Generics Act
Introduced
27 June 2006
Last action
—
Status
Read twice and referred to the Committee on Commerce, Science, and Transportation. (text of measure as introduced in Senate: CR S6578)
Sponsors
—
Subjects
Discovery layer
Source updated
15 August 2025
Summary
Preserve Access to Affordable Generics Act - Amends the Federal Trade Commission Act to deem it to be an unfair method of competition affecting commerce for a person, in connection with the sale of a drug product, to be a party to any agreement resolving or settling a patent infringement claim in which: (1) an abbreviated new drug (generic) application filer receives anything of value; and (2) such filer agrees not to research, develop, manufacture, market, or sell the generic product for any period. Excludes a resolution or settlement that includes no more than the right to market the generic product prior to the expiration of the patent.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 27 June 2006
Introduced in Senate (PDF)
Introduced in Senate · EN · 27 June 2006
Introduced in Senate
summary · EN · 27 June 2006
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/109th-congress/senate-bill/3582
- Open data entity: https://api.congress.gov/v3/bill/109/s/3582